Literatur
-
1
Claudon M, Cosgrove D, Albrecht T. et al .
Guidelines and good clinical practice recommendations for contrast-enhanced ultrasound (CEUS) – update 2008.
Ultraschall in Med.
2008;
29
28-44
-
2
Albrecht T, Blomley M, Bolondi L. et al .
Guidelines for the use of ultrasound. January 2004.
Ultraschall in Med.
2004;
25
249-256
-
3
Oldenburg A, Albrecht T.
Sonografische Leberdiagnostik bei Tumorpatienten ohne und mit Kontrastmittel.
Ultraschall in Med.
2008;
29
488-498
-
4
Seitz K.
CEUS for Liver Tumors: Facts, Studies, Relevance and Reality in the Clinical Routine.
Ultraschall in Med.
2008;
29
485-487
-
5
Herbay von A, Haeussinger D, Gregor M. et al .
Characterization and detection of hepatocellular carcinoma (HCC: comparison of the ultrasound agents Sono Vue (BR 1) and Levovist (SH U 408).
Ultraschall in Med.
2007;
28
168-175
-
6
Seitz K, Judmaier G.
The Extended Repertoire of Sonography: Contrastenhancement, Radio Frequency Ablation and Puncture.
Ultraschall in Med.
2007;
28
158-160
-
7
Strobel D, Seitz K, Blank W. et al .
Contrast-enhanced Ultrasound for the Characterization of Focal Liver Lesions – Diagnostic Accuracy in Cinical practice (DEGUM multicenter trial).
Ultraschall in Med.
2008;
29
499-505
-
8
Seitz K.
Leipzig 2007 – an Internal Retrospect.
Ultraschall in Med.
2008;
29
428-433
-
9
Dietrich C F.
Update on Contrast Enhanced Ultrasound in Abdominal and Vascular Imaging.
Ultraschall in Med.
2008;
29
S188-S202
-
10
Seitz K.
Contrast Enhanced Sonography of the Abdomen and Retroperitoneum.
Ultraschall in Med.
2007;
28
82-84
-
11
Bleuzen A, Huang C, Olar M. et al .
Diagnostic Accuracy of Contrast-Enhanced Ultrasound in Focal Lesions of the Liver Using Cadence Contrast pulse Sequencing.
Ultraschall in Med.
2006;
27
40-48
-
12
Bernatik T. et al .
DEGUM-Multizenterstudie zur KM-Sonografie bei B-Bild-morphologisch unklaren Leberläsionen: Wann, wie oft und warum werden einige Läsionen in der Kontrastmittelsonografie falsch diagnostiziert?.
Ultraschall in Med.
2008;
29
S129
-
13
Mandry D, Bressenot A, Galloy M A. et al .
Contrast-Enhanced Ultrasound inFibro-Lammellar Hepatocellular Carcinoma: A Case Report.
Ultraschall in Med.
2007;
28
547-553
-
14
Seitz K.
Gas and Bubbles: from Obstacle to Diagnostic Feature.
Ultraschall in Med.
2007;
28
576-577
-
15
Konopke R, Bunk A, Kersting S.
Contrast-Enhanced Ultrasonography in Patients with Colorectal Liver Metastases after Chemothrapy.
Ultraschall in Med.
2008;
29
S203-S209
-
16
Michaeli P. et al .
Sonovue® eignet sich nicht zur nichtinvasiven Bestimmung des Leberfibrostadiums bei chron. Hepatitis C.
Ultraschall in Med.
2008;
29
S140
-
17
Strobel D, Kleinecke C, Hänsler J. et al .
Contrast-Enhanced Sonography of Hepatocellular Carcinomas – Correlation with Histological Differentiation.
Ultraschall in Med.
2005;
26
270-276
-
18
Bauditz J, Schade T, Wermke W.
Sonografische Diagnostik des hilären cholangiozellulären Karzinoms mittels Echosignalverstärker.
Ultraschall in Med.
2007;
28
161-167
-
19
Dörffel Y, Wermke W.
Neuroendocrine Tumors: Characterization with Contrast-Enhanced Ultrasonography.
Ultraschall in Med.
2008;
29
506-524
-
20
Konopke R, Kersting S, Saeger H D. et al .
Detection of liver lesions by contrast-enhanced ultrasound – comparison to intraoperative findings.
Ultraschall in Med.
2005;
26
107-113
-
21
Heide R, Strobel D.
Kontrastmittelsonographie der Leber – Mittelklassegerät versus High-End-Gerät.
Ultraschall in der Med.
2007;
28 (S1)
S34
-
22
Albrecht T.
Contrast-Enhanced Ultrasound has come of Age.
Ultraschall in Med.
2008;
29
S187
-
23
ter Haar G.
Bubble Trouble?.
Ultraschall in Med.
2008;
29
550-551
-
24
Barnett S B, Duck F, Ziskin M.
Recommendations of the safe use of ultrasound contrast agents.
Ultrasound Med Biol.
2007;
33
173-174
-
25
Piscaglia F, Bolondi L.
The safety of Sonovue in abdominal applications: retrospective analysis of 23 188 investigations.
Ultrasound Med Biol.
2005;
32
1369-1375
-
26
Burns P, Wilson S.
Focal Liver Masses: Enhancement patterns of contrast-enhanced images – concordance of US scans with CT scans and MR images.
Radiology.
2007;
242
162-174
-
27
Dietrich C F, Mertens J C, Braden B. et al .
Contrast-Enhanced Ultrasound of Histologically Proven Liver Hemangiomas.
Hepatology.
2007;
45
1139-1145
-
28
Dietrich C F, Kratzer W, Strobel D. et al .
Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI.
World J Gastroenterol.
2006;
12
1699-1705
-
29
Xu H X, Liu G J, Lu M D. et al .
Characterization of small focal liver lesions using real-time contrast-enhanced. Diagnostic performance analysis in 200 patients.
J Ultrasound Med.
2006;
25
349-361
-
30
Solbiati I, Ierace T, Tonolini M. et al .
Guidance and monitoring of radiofrequency liver tumor ablation with contrast-enhanced ultrasound.
Eur J Radiol.
2004;
51
S19-S23
-
31
Stetter R, Barreiros A P, Galle P R. et al .
Erstdiagnose eines echoarmen Lebertumors mittels Sonographie und CEUS bei unauffälligem CT und MRT – ein Plädoyer für den Ultraschall.
Ultraschall in der Medizin.
2007;
28
S1
-
32
Tranquart F, Correas J M, Ladam Marcus V. et al .
Real-time contrast-enhanced ultrasound in the evaluation of focal liver lesions: diagnostic efficacy and economical issues from a French multicentric study.
J Radiol.
2009;
90
109-122
-
33
Oldenburg A, Hohmann J, Foert E. et al .
Detection of Hepatic Metastases with low MI Real Time Contrast Enhanced Sonography and SonoVue®.
Ultraschall in Med.
2007;
28
277-284
-
34
Strobel D.
Tumor-Specific Vascularisation Pattern of Liver Metastasis, Hepatocellular Carcinoma, Hemangioma and Focal Nodular Hyperplasie in the Differential Diagnosis of 1349 Liver Lessions in Contrast-Enhanced Ultrasound (CEUS).
Ultraschall in Med.
2009;
30
376-382
-
35
Seitz K.
Contrast-Enhanced Ultrasound (CEUS) for the Characterization of Liver Lessions – Prospective Comparison in Clinical Practice CEUS vs. CT (DEGUM Multicenter Trial). Parts of this Manuscript were presented at the Ultrasound Dreiländertreffen 2008, Davos.
Ultraschall in Med.
2009;
30
383-389
-
36
Nürnberg D, Jung A, Schmieder C. et al .
Was kostet die Sonographie – Ergebnisse einer Kosten- und Prozessanalyse an einem Versorgungskrankenhaus.
Ultraschall in Med.
2008;
29
405-417
-
37
Mostbeck G.
CEUS aus radiologischer Sicht: Traum und Wirklichkeit.
Ultraschall in Med.
2009;
30
125-127
-
38
Giesel F L, Delorme S, Ribbel R. et al .
Contrast-Enhanced Ultrasound for the Characterization of Incidental Liver Lesions – An Economical Evaluation in Comparison with Multi-Phase Computed Tomography.
Ultraschall in Med.
2009;
30
259-268
-
39
Faccioli N, D’Onofrio M, Comai A. et al .
Contrast-enhanced ultrasonography in the characterization of benign liver lesions: activity-based cost analysis.
Radiol Med.
2007;
112
810-820
-
40
Canaris G I, Mavor N R. et al .
The Colorado thyroid diseases prevalence study.
Arch Intern Med.
2000;
160
526-534
-
41
Hollowell J G, Staehling N W, Flanders W D. et al .
Serum TSH, T(4) and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).
J Clin Endocrinol Metab.
2002;
87
489-49 942
-
42
Surks M I, Ortiz E, Daniels G H. et al .
Subclinical thyroid disease: scientific review and guidelines for diagnosis and management.
JAMA.
2004;
291
228-23 843
-
43
Dillmann J R, Ellis J H, Cohan R H. et al .
Frequency and severity of acute allergic-like reactions to gadolinium-containing i. v. contrast media in children and adults.
Am J Roentgenol.
2007;
189
1533-1538
-
44
Li A, Wong C S, Wong M K. et al .
Acute adverse reactions to magnetic resonance contrast media – gadolinium chelates.
Br J Radiol.
2006;
79
368-371
-
45
Berrington de Gonzalez A, Darby S.
Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries.
Lancet.
2004;
363
345-351
-
46
Brenner D J, Hall E J.
Computed tomography – an increasing source of radiation exposure.
N Engl J Med.
2007;
357
2277-2284
-
47
Brix G, Nekolla E, Griebel J.
Strahlenexposition von Patienten durch diagnostische und interventionelle Röntgenanwendungen – Fakten, Bewertung und Trends.
Radiologe.
2003;
45
340-349
-
48
Linton O W, Mettler F A.
National conference on dose reduction in CT, with an emphasis on pediatric patients.
Am J Roentgenol.
2003;
181
321-949
-
49 Müller W U. Genetische Effekte u. Kanzerogenese. Bamberg M, Molls M, Sack H Radioonkologie Grundlagen München; Zuckschwerdt Verlag 2003: 266-274
-
50
Shannoun F, Blettner M, Schmidberger H. et al .
Strahlenschutz in der diagnostischen Radiologie.
Dtsch Ärztebl.
2008;
105
41-46
Prof. Dr. Bernd Braun
Medizinische Klinik I, Klinikum am Steinenberg, Kreiskliniken Reutlingen
Telefon: ++ 49/71 21/2 00-34 17
Fax: ++ 49/71 21/2 00-35 74
eMail: braun_b@kreiskliniken-reutlingen.de
